Shu‐Leong Ho

5.8k total citations · 1 hit paper
52 papers, 2.6k citations indexed

About

Shu‐Leong Ho is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shu‐Leong Ho has authored 52 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 21 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shu‐Leong Ho's work include Parkinson's Disease Mechanisms and Treatments (19 papers), Mitochondrial Function and Pathology (11 papers) and Nuclear Receptors and Signaling (11 papers). Shu‐Leong Ho is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (19 papers), Mitochondrial Function and Pathology (11 papers) and Nuclear Receptors and Signaling (11 papers). Shu‐Leong Ho collaborates with scholars based in Hong Kong, United Kingdom and China. Shu‐Leong Ho's co-authors include D. Ramsden, Philip Wing‐Lok Ho, Tao Xie, Shirley Yin-Yu Pang, Huifang Liu, Chi-Ting Leung, Koon‐Ho Chan, Michelle Hiu-Wai Kung, Eunice Eun Seo Chang and Kay Cheong Teo and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Stroke.

In The Last Decade

Shu‐Leong Ho

52 papers receiving 2.5k citations

Hit Papers

The interplay of aging, genetics and environmental factor... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Leong Ho Hong Kong 31 1.1k 873 619 518 301 52 2.6k
Silvia Cerri Italy 26 1.1k 1.0× 714 0.8× 473 0.8× 584 1.1× 205 0.7× 61 2.3k
María Isabel Behrens Chile 30 1.1k 1.0× 1.5k 1.7× 967 1.6× 822 1.6× 342 1.1× 90 3.5k
Joseph Jankovic United States 25 1.4k 1.3× 776 0.9× 609 1.0× 672 1.3× 646 2.1× 41 2.8k
Patrizia Longone Italy 31 983 0.9× 881 1.0× 347 0.6× 913 1.8× 232 0.8× 63 2.6k
Hortensia Alonso‐Navarro Spain 29 1.4k 1.3× 510 0.6× 295 0.5× 552 1.1× 432 1.4× 148 2.6k
Anmu Xie China 25 743 0.7× 723 0.8× 407 0.7× 397 0.8× 204 0.7× 99 2.1k
Gilbert Ho United States 21 675 0.6× 686 0.8× 1.1k 1.7× 718 1.4× 139 0.5× 48 2.4k
Agata Adamczyk Poland 28 504 0.5× 601 0.7× 572 0.9× 383 0.7× 141 0.5× 70 2.1k
Mamoru Shibata Japan 26 494 0.5× 706 0.8× 536 0.9× 546 1.1× 411 1.4× 90 2.5k
Wenjie Xie China 23 822 0.8× 687 0.8× 329 0.5× 723 1.4× 422 1.4× 55 2.1k

Countries citing papers authored by Shu‐Leong Ho

Since Specialization
Citations

This map shows the geographic impact of Shu‐Leong Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Leong Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Leong Ho more than expected).

Fields of papers citing papers by Shu‐Leong Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Leong Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Leong Ho. The network helps show where Shu‐Leong Ho may publish in the future.

Co-authorship network of co-authors of Shu‐Leong Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Leong Ho. A scholar is included among the top collaborators of Shu‐Leong Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Leong Ho. Shu‐Leong Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Philip Wing‐Lok, et al.. (2023). In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G  mutant mouse model of Parkinson's disease. Brain and Behavior. 13(2). e2886–e2886. 4 indexed citations
2.
Ho, Philip Wing‐Lok, Chi-Ting Leung, Huifang Liu, et al.. (2022). Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects. npj Parkinson s Disease. 8(1). 115–115. 10 indexed citations
3.
Pang, Shirley Yin-Yu, Philip Wing‐Lok Ho, Huifang Liu, et al.. (2022). LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease. Translational Neurodegeneration. 11(1). 5–5. 51 indexed citations
4.
Jiang, Lin, Hui Jiang, Sheng Dai, et al.. (2021). Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases. Nucleic Acids Research. 50(6). e34–e34. 5 indexed citations
5.
Biffi, Alessandro, Kay Cheong Teo, William Leung, et al.. (2021). Impact of Uncontrolled Hypertension at 3 Months After Intracerebral Hemorrhage. Journal of the American Heart Association. 10(11). e020392–e020392. 20 indexed citations
6.
Lee, Yee-Ki, Yee‐Man Lau, Kwong‐Man Ng, et al.. (2015). Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. International Journal of Cardiology. 203. 964–971. 30 indexed citations
7.
Yao, Nailin, Shirley Yin-Yu Pang, Charlton Cheung, et al.. (2014). Resting activity in visual and corticostriatal pathways in Parkinson's disease with hallucinations. Parkinsonism & Related Disorders. 21(2). 131–137. 53 indexed citations
8.
Li, Miaoxin, Johnny S. H. Kwan, Suying Bao, et al.. (2013). Predicting Mendelian Disease-Causing Non-Synonymous Single Nucleotide Variants in Exome Sequencing Studies. PLoS Genetics. 9(1). e1003143–e1003143. 102 indexed citations
9.
10.
Ho, Philip Wing‐Lok, Jessica Wing-Man Ho, Huifang Liu, et al.. (2012). Uncoupling Protein-4 (UCP4) Increases ATP Supply by Interacting with Mitochondrial Complex II in Neuroblastoma Cells. PLoS ONE. 7(2). e32810–e32810. 31 indexed citations
11.
Ho, Philip Wing‐Lok, et al.. (2012). Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease. Translational Neurodegeneration. 1(1). 3–3. 68 indexed citations
12.
Cheung, Raymond Tak Fai, et al.. (2011). Ischemic stroke related to intracranial branch atheromatous disease and comparison with large and small artery diseases. Journal of the Neurological Sciences. 303(1-2). 80–84. 34 indexed citations
13.
Ho, Philip Wing‐Lok, Andrew Chi‐Yuen Chu, Jessica Wing-Man Ho, et al.. (2010). Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity. Free Radical Biology and Medicine. 49(6). 1023–1035. 69 indexed citations
14.
Ho, Philip Wing‐Lok, Huifang Liu, Jessica Wing-Man Ho, et al.. (2009). Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP+ Toxicity in Neuronal Cells. Neurotoxicity Research. 17(4). 332–343. 52 indexed citations
15.
Chu, Andrew Chi‐Yuen, Philip Wing‐Lok Ho, Jessica Wing-Man Ho, et al.. (2008). Mitochondrial UCP4 attenuates MPP+- and dopamine-induced oxidative stress, mitochondrial depolarization, and ATP deficiency in neurons and is interlinked with UCP2 expression. Free Radical Biology and Medicine. 46(6). 810–820. 65 indexed citations
16.
Yang, Jian, Pek‐Lan Khong, Yanxin Wang, et al.. (2008). Manganese‐enhanced MRI detection of neurodegeneration in neonatal hypoxic‐ischemic cerebral injury. Magnetic Resonance in Medicine. 59(6). 1329–1339. 34 indexed citations
17.
Ho, Philip Wing‐Lok, et al.. (2005). Methyl‐4‐phenylpyridinium ion modulates expression of mitochondrial uncoupling proteins 2, 4, and 5 in catecholaminergic (SK‐N‐SH) cells. Journal of Neuroscience Research. 81(2). 261–268. 24 indexed citations
18.
Ho, Shu‐Leong, et al.. (2004). High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome. Leukemia & lymphoma. 46(2). 289–292. 3 indexed citations
19.
Tsang, Kin‐Lun, Iris Chi, Shu‐Leong Ho, et al.. (2002). Translation and validation of the standard Chinese version of PDQ‐39: A quality‐of‐life measure for patients with Parkinson's disease. Movement Disorders. 17(5). 1036–1040. 56 indexed citations
20.
Xie, Tao, Shu‐Leong Ho, & D. Ramsden. (1999). Characterization and Implications of Estrogenic Down-Regulation of Human Catechol-O-Methyltransferase Gene Transcription. Molecular Pharmacology. 56(1). 31–38. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026